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Received August 22, 2011; accepted March 5, 2012AbstractBackground: An elevated annual incidence rate of hip fracture has been reported among elderly Taiwanese. Moreover, bone mineral density
(BMD) is the single most reliable predictor of fragility fractures. We aimed to identify the association between gene sequence variants and hip
BMD in postmenopausal Taiwanese women.
Methods: We prospectively analyzed data from 163 postmenopausal Taiwanese women to test an association between rs7524102, rs6696981, or
rs6993813 single-nucleotide polymorphisms (SNPs) and hip BMD.
Results: Our study showed that rs6993813 (osteoprotegerin gene) and rs6696981 (ZBTB40 gene) SNPs have an opposite association with hip
BMD. For rs6993813 genotypic frequencies, the adjusted odds ratio for hip osteoporosis was 9.53 for individuals with T/T minor allele
homozygotes, compared with that of participants with C/C wild-type homozygotes. Hip BMD also had an association with rs6993813 SNPs,
especially in T/T minor allele homozygotes. For rs6696981 SNPs, hip BMD in G/T heterozygotes and at least one mutated T allele was higher
than that in wild-type G/G homozygotes.
Conclusion: The gene sequence variant rs6993813 reduced hip BMD and increased the risk of hip osteoporosis, whereas rs6696981 increased hip
BMD in postmenopausal Taiwanese women. This indicated that the two SNPs may provide some explanation for the high risk of hip fracture in
this population.
Copyright  2012 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Osteoporosis is a common disease that predisposes people
to fragility fractures at the spine, hip, forearm, or other skeletal
sites.1 Vertebral fractures are the most common type of oste-
oporotic fractures and are associated with significant
morbidity and 1.2e2.3 times increased relative mortality rates.
However, hip fractures can lead to an excess mortality rate of* Corresponding author. Dr. Ko-Hsiu Lu, Department of Orthopedics,
Chung Shan Medical University Hospital, 110, Section 1, Chien-Kuo N.
Road, Taichung 402, Taiwan, ROC.
E-mail address: cshy307@csh.org.tw (K.-H. Lu).
1726-4901/$ - see front matter Copyright  2012 Elsevier Taiwan LLC and the C
http://dx.doi.org/10.1016/j.jcma.2012.05.0045e20%, mostly attributable to medical complications,2
morbidity that severely restricts patients, and the substantial
economic costs to society.3 Although elderly women of
European descent are at the highest risk,4 this disorder affects
the elderly of both sexes and all racial groups. Similarly, the
aging of the Taiwanese population has caused a marked
increase in the prevalence of age-related osteoporotic frac-
tures, especially fractures of the hip.5,6
The incidence of hip fracture in the elderly apparently
occurs at a substantially reduced frequency in the ethnic
Chinese population as compared to that of some Caucasian
populations, based on hospital discharge records.7e9 However,
hip fracture incidence is relatively high in one of the majorhinese Medical Association. All rights reserved.
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database of Taiwan, a high annual incidence rate of hip fracture
among elderly Taiwanese has been reported.11 Unlike Chinese,
the incidence of hip fracture in elderly Taiwanese women is
similar to that of US white women, but the incidence in elderly
Taiwanese men is higher than that of US white men.
Since the World Health Organization published diagnostic
criteria for osteoporosis in 1994,12 the measurement of bone
mineral density (BMD) at multiple skeletal sites is used in the
clinical diagnosis of osteoporosis13 and the assessment of
fracture risk.14 It is well known that low BMD is an important
risk factor for fracture,15 and the risk of osteoporotic fracture
is a complex disease regulated by both genetic and environ-
mental factors. Although individual polymorphisms in several
candidate genes accounting for only a small portion of the
genetic contribution to BMD regulation has been reported,16,17
there is abundant evidence for a genetic contribution to vari-
ation in BMD, with heritability estimates of up to 80%.18,19
Numerous candidate genes have an association with BMD
and with osteoporotic fractures.20,21 Several quantitative trait
loci have also yielded a linkage with BMD.22
To clear up the question as to why the ethnic Taiwanese
population has higher hip fracture rates, we require an
explanation, and there may be a secular effect making the
differences more profound. Although several mechanisms
have been suggested for the higher incidence rates of hip
fracture in Taiwan,11 we hypothesized that a genetic compo-
nent with the heritability of hip fracture in the elderly
Taiwanese plays an important role in the pathogenesis of
osteoporosis. Because osteoporosis is a highly heritable and
multifactorial trait, the aim of this study is to identify genetic
loci that are associated with low BMD and high fragility
fractures of the hip. Sequence variants in the genomic regions
rs7524102 and rs6696981, located on the 1p36 (the zinc finger
and BTB domain containing 40 gene, ZBTB40), and
rs6993813 on 8q24 (osteoprotegerin gene, OPG), have
recently been reported to be significantly associated with hip
BMD and osteoporotic fractures.23e29 Thus, we evaluated the
effect of rs7524102, rs6696981, and rs6993813 single-
nucleotide polymorphisms (SNPs) on hip BMD in post-
menopausal Taiwanese women.
2. Methods2.1. Participants and samples collectionA total of 163 postmenopausal Taiwanese women were
recruited into this study (Table 1). Their body weight (kg),
height (cm), body mass index (BMI), and hip BMD were
measured. The women were divided into two groups: the first
with a T-score of greater than 2.5 standard deviation (SD)
(normal and osteopenia), the second with T-score less than
or equal to 2.5 SD (osteoporosis) groups in accordance
with the World Health Organization’s published diagnostic
criteria for osteoporosis.12 A questionnaire was administered
to collect information regarding age, smoking status, caffeine
consumption, and calcium tablet intake. This study wasconducted in accordance with the principles in the Declaration
of Helsinki, and was approved by the Institutional Review
Board of Zuoying Armed Forces General Hospital, Taiwan.
All participants gave informed consent for the use of their data
and blood specimens. Venous blood specimens obtained from
each participant were placed in tubes containing EDTA, and
were immediately centrifuged and stored at 80C for
genomic DNA extraction.2.2. Bone mineral density measurementsUsing Hologic QDR 2000 (Hologic Corp., Waltham MA,
USA), dual-energy X-ray absorptiometry measurements at the
hip, total hip measurements were obtained in all patients.
Standardized BMD was calculated and corrected for sex, age,
and weight in each participating individual.2.3. DNA extractionFollowing the manufacturer’s protocol, DNA extraction
was performed using the DNeasyTM Kit (Qiagen, Valencia,
CA, USA). Briefly, the blood was digested with 0.5 mg/mL
proteinase K in 400 mL cell-lysis solution for 24 hours at 55C
until the blood was completely lysed. After adding 200 mL
absolute ethanol to the lysed sample, the mixture was trans-
ferred into the DNeasy mini-column and centrifuged for
1 minute at 8000 rpm. The DNeasy mini-column was washed
with 500 mL washing buffer and centrifuged for 1 minute at
8000 rpm. Finally, the DNA was eluted in a clean 1.5-mL
microcentrifuge tube.2.4. SNP selection and genotypingDNA from venous blood was extracted and amplified by
allele-specific polymerase chain reaction using allele-specific
sense and antisense primers (Table 2).30 Genotyping was
completed on each participant for three tagging SNPs from
two chromosomal regions: 1p36 (ZBTB40; rs7524102,
rs6696981) and 8q24 (OPG; rs6993813).2.5. Statistical analysisAll data were expressed as mean  SD. Linear regression
analysis was used for the correlation between age, height,
weight or BMI, and BMD of the hip. The Student t-test and
analysis of variance were used to analyze the differences for
continuous variables between groups two and three, respec-
tively. Chi-square test was used to test the differences for
categorical variables. HardyeWeinberg equilibrium was
assessed using a goodness-of-fit chi-square test for biallelic
markers. The odds ratios (ORs) with 95% confidence intervals
(CIs) of the association between genotype frequencies and hip
osteoporosis risk were estimated by logistic regression models,
after controlling for other covariates. Statistical significance
was set at p < 0.05.
Table 1
Distributions of demographical characteristics of the popkulation.
Demographic variables Total (n ¼ 163) T-score >2.5 (n ¼ 90) T-score 2.5 (n ¼ 73) p
Age (y) 61.47  8.46 57.97  5.97 65.78  9.10 <0.001a
Height (cm) 155.74  9.80 158.41  5.32 153.83  4.35 <0.001a
Weight (kg) 58.52  12.59 61.79  10.06 53.11  8.06 <0.001a
BMI 23.60  3.40 24.56  3.30 22.43  3.17 <0.001a
Smoking
No n ¼ 162 n ¼ 90 n ¼ 72 0.265b
Yes n ¼ 1 n ¼ 0 n ¼ 1
Caffeine
No n ¼ 135 n ¼ 73 n ¼ 62 0.520b
Yes n ¼ 28 n ¼ 17 n ¼ 11
Calcium
No n ¼ 103 n ¼ 64 n ¼ 39 0.020b
Yes n ¼ 60 n ¼ 26 n ¼ 34
Values are mean  SD.
BMI ¼ body mass index.
a Student’s t-test was used to analyze differences in age, height, and weight between T-score >2.5 and T-score 2.5 groups.
b Chi-square test was used to test differences in smoking status, caffeine consumption, or calcium intake between “yes” and “no” groups.
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women with T-score >2.5 SD (73 normal and 17 osteope-
nia), and 73 women with T-score 2.5 SD. Age, body
weight, height, and BMI all showed significant differences
between T-score 2.5 and T-score >2.5 groups
( p < 0.001, p < 0.001, p < 0.001, and p < 0.001, respec-
tively). Significant differences were found between the
numbers in calcium tablet intake and non-intake groups
( p ¼ 0.019), but were not observed between that in either the
smoking and nonsmoking groups or the caffeine consumption
and non-caffeine consumption groups. Furthermore, declines
in BMD correlated significantly with decreased body heightTable 2
Sequences of sense and antisense primers used in SNPs and the expected sizes
of resultant allele-specific PCR products.






R 50-AGACGCTCTGCAAGTTCACA-30 222 GG
A-R 50-AGGAGAAAT TTGAGATGCTA-30 81
G-R 50-AGGAGAAAT TTGAGATGCTG-30 81
rs6696981 GG
F 50-GAGCAT TTAGCCAGGC ACTC-30 GT
R 50- CAGGCACATCCACCCTATCT-30 171 TT
G-R 50-CCTGGAA GCGGTAGCTG TAG 142
T-R 50-CCTGGAA GCGGTAGCTG TAT 142
rs6993813 CC
F 50-TCCGGGATAATCTCCCTTTT-30 CT
R 50-CGGGGTCCACTAACCTAACC-30 255 TT
C-R 50-CAAGTTCTGGAGATTAGGGCTC-30 120
T-R 50-CAAGTTCTGGAGATTAGGGCTT-30 120
PCR ¼ polymerase chain reaction; SNP ¼ single-nucleotide polymorphism.(Y ¼ 19.980 þ 0.116X, r2 ¼ 0.228, p < 0.001) and decreased
body weight (Y ¼ 5.873 þ 0.070X, r2 ¼ 0.176, p < 0.001),
but also with increased age (Y ¼ 3.661 e 0.089X, r2 ¼ 0.252,
p < 0.001) using linear regression.3.2. SNPs of rs7524102, rs6696981, and rs6993813The SNPs from rs7524102, rs6696981, and rs6993813
appeared to vary among individual blood samples. Although
the frequency of both rs7524102 and rs6696981 SNPs in this
population was in HardyeWeinberg equilibrium, the
rs6993813 SNP did not demonstrate HardyeWeinberg equi-
librium ( p < 0.05). We still calculated ORs to measure the
association, because the HardyeWeinberg equilibrium test
cannot be used to adequately justify the validity of ORs esti-
mates in case-control studies. For the rs7524102 genotype, the
frequencies of A allele and G allele in the T-score >2.5
group were 76.7% (69/90) and 23.3% (21/90), respectively. In
the T-score 2.5 group, the frequencies of A allele and G
allele were 80.14% (58.5/73) and 19.86% (14.5/73), respec-
tively. For rs6696981 genotype, the frequencies of G allele and
T allele in the T-score >2.5 group were 77.8% (70/90) and
22.2% (20/90), respectively. In the T-score 2.5 group, the
frequencies of G allele and T allele were 84.93% (62/73) and
15.07% (11/73), respectively. For the rs6993813 genotype, the
frequencies of C allele and T allele in the T-score >2.5 group
were 70.0% (63/90) and 30.0% (27/90), respectively. In the T-
score 2.5 group, the frequencies of C allele and T allele
were 59.59% (43.5/73) and 40.41% (29.5/73), respectively.3.3. Association between SNPs and osteoporosisFor rs6993813 genotypic frequencies, the adjusted OR
(AOR) for hip osteoporosis was 9.53 (95% CI, 1.22e64.27)
for individuals with T/T minor allele homozygotes compared
with that of patients with C/C wild-type homozygotes, defined
as 1 (Table 3). However, there was no significant difference
Table 3
AOR and 95% CIs of T-score >2.5 and T-score 2.5 associated with genotypic frequencies.
Genotype T-score >2.5 T-score 2.5 OR (95% CI) AOR (95% CI)
(n ¼ 90) (%) (n ¼ 73) (%)
rs7524102
AA 50 (55.56%) 45 (61.64%) 1.00 1.00
AG 38 (42.22%) 27 (36.99%) 0.79 (0.42e1.49) 0.87 (0.38e2.00)
GG 2 (2.22%) 1 (1.37%) 0.56 (0.05e6.34) 2.88 (0.13e62.71)
AA 50 (55.56%) 45 (61.64%) 1.00 1.00
AG or GG 40 (6.44%) 28 (38.36%) 0.78 (0.42e1.46) 0.91 (0.40e2.06)
rs6696981
GG 52 (57.78%) 52 (71.23%) 1.00 1.00
GT 36 (40.00%) 20 (27.40%) 0.56 (0.29e1.08) 0.47 (0.20e1.12)
TT 2 (2.22%) 1 (1.37%) 0.50 (0.04e5.69) 2.23 (0.10e49.38)
GG 52 (57.78%) 52 (71.23%) 1.00 1.00
GT or TT 38 (42.22%) 21 (28.77%) 0.55 (0.29e1.07) 0.50 (0.21e1.18)
rs6993813
CC 37 (41.11%) 22 (30.14%) 1.00 1.00
CT 52 (57.78%) 43 (58.90%) 1.39 (0.72e2.70) 0.86 (0.34e2.17)
TT 1 (1.11%) 8 (10.96%) 13.46 (1.58e114.90) 9.53 (1.22e64.27)
CC 37 (41.11%) 22 (30.14%) 1.00 1.00
CT or TT 53 (58.89%) 51 (69.86%) 1.62 (0.84e3.11) 1.02 (0.41e2.52)
ORs with 95% CI were estimated by logistic regression models. AORs with 95% CI were estimated by multiple logistic regression models, after controlling for
age, height, weight, and calcium intake for each estimated variable. AOR ¼ adjusted odds ratio; CI ¼ confidence interval.
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homozygotes. Furthermore, individuals with at least one
mutated C allele were classified into the same subgroup, and
individuals with homozygous T/T alleles were assigned to
another subgroup. For individuals with at least one mutated T
allele, the AOR for hip osteoporosis was 1.02 (95% CI,
0.41e2.52), but no significant difference was observed. There
were no significant differences in any allele distribution for
rs7524102 or rs6696981 SNPs.3.4. Association between SNPs and BMDResults of hip BMD and genotype distributions of
rs7524102, rs6696981, and rs6993813, including differences
between polymorphic variants and wild-type homozygotes, are
shown in Table 4. Hip BMD had differences betweenTable 4
Hip BMD in relation to the allele distribution of the SNPs.
Genotype n Hip BMD Genotype n
rs7524102 rs6696981
AA 95 1.96  1.41 GG 104
AG 65 1.61  1.57 GT 56
GG 3 0.43  1.96 TT 3
F value 2.377
AA 95 1.96  1.41 GG 104
AG þ GG 68 1.56  1.59 GT þ TT 59
Pa 0.088
Values are mean  SD.
BMD ¼ bone mineral density; SNP ¼ single-nucleotide polymorphism.
a Student’s t-test was used to analyze the difference of hip BMD between other
* p < 0.05, analysis of variance with Bonferroni posteriori comparison.
** p < 0.01, analysis of variance with Bonferroni posteriori comparison
y Significantly different, at p < 0.05, when compared to the wild type.polymorphic variants and wild-type homozygotes in the OPG
gene (rs6993813, p < 0.001). For rs6696981 SNP, hip BMD in
G/T heterozygotes ( p < 0.05) and in G/T and T/T minor allele
homozygotes ( p ¼ 0.008) was significantly higher than that in
the wild-type G/G homozygotes. Although hip BMD in T/T
minor allele homozygotes also seemed to be higher than G/G
homozygotes, it did not show significant difference (n ¼ 3).
For rs7524102 SNP, no significant differences were observed
in any allele distribution.
4. Discussion
We investigated the effect of rs7524102, rs6696981, and
rs6993813 SNPs on hip BMD in elderly Taiwanese women
and, interestingly, found an opposite association of OPG and
ZBTB40 polymorphisms with hip BMD. The AOR for hipHip BMD Genotype n Hip BMD
rs6993813
2.03  1.41 CC 59 1.61  1.42
1.43  1.55y CT 95 1.77  1.53y
0.43  1.96 TT 9 3.27  0.82y
4.302* 5.054**
2.03  1.41 CC 59 1.61  1.42
1.38  1.57 CT þ TT 104 1.90  1.54
0.008 0.232
than the wild type and the wild type.
339T.-H. Chao et al. / Journal of the Chinese Medical Association 75 (2012) 335e340osteoporosis was 9.53 for individuals with T/T minor allele
homozygotes of rs6993813, compared to individuals with C/C
wild-type homozygotes. Also, BMD of the hip had differences
between polymorphic variants and wild-type homozygotes in
the rs6993813 SNP. In contrast, hip BMD in G/T heterozy-
gotes and in G/T and T/T minor allele homozygotes of the
rs6696981 SNP was significantly higher than that in wild-type
G/G homozygotes. Thus, the minor allele homozygotes of
rs6993813 had a strong effect on decreasing hip BMD and the
development of hip osteoporosis, while at least one mutated T
allele of the rs6696981 SNP possessed a protective effect by
increasing BMD of the hip, and this effect was independent of
hip osteoporosis.
Osteoporosis increases in incidence with age and is an
important health challenge to hundreds of millions of elderly
individuals worldwide; not surprisingly, reduced BMD was
directly associated with increased age in these elderly
Taiwanese women. Consistent with significant differences in
body height and weight between low BMD and high BMD
individuals,29,31 BMD correlated significantly with body
height, weight, and BMI in the study. Because osteoporosis is
a common disease with a heritable component characterized
by decreasing BMD and increasing risk of fragility frac-
tures,18,19 polymorphisms in several candidate genes have
been reported to be associated with bone mass or osteoporotic
fractures.24 Despite the focus on BMD because of its high
heritability,18,19 medical and environmental factors such as
diet and specific nutrients contribute to interact with genetic
polymorphisms to regulate bone mass. With respect to
significant differences in calcium tablet intake or not between
T-score 2.5 and T-score >2.5 groups, the women who
had been diagnosed as osteoporotic presumably should have
had an increased calcium tablet intake in an effort to decrease
bone fragility and susceptibility to fracture. Nevertheless,
calcium tablet supplementation does not appear to possess
a significantly increasing effect on BMD postmenopausally.32
Both BMD and osteoporotic fractures have high genetic
determinations.33,34 BMD is the single best predictor of
fragility fractures,14 and is currently the predominant study
phenotype for osteoporosis.13 The OPG gene has been previ-
ously shown to be important to the biologic characteristics of
bone through the regulation of osteoclastogenesis,23,35 and
Wnt signaling controls the process of bone resorption by
negatively regulating TNFRSF11B expression in osteoblasts.36
In addition to being associated with osteoporotic fractures,
rs7524102 and rs6696981 on the 1p36 (ZBTB40), and
rs6993813 on 8q24 (OPG) have been reported to be the most
important quantitative trait loci for BMD of the hip,23e29
although the SNPs tested are different. Furthermore, 98% of
Taiwan’s population is made up of Han Chinese, while 2% are
Taiwanese aborigines according to official governmental
statistics. However, the composite category of “Taiwanese
population” is often characterized by many Taiwanese to
include a significant population of at least four constituent
ethnic groups: the Hoklo (70%), the Hakka (15%), Mainlander
(13%), and Taiwanese aborigines (2%).37,38 For these reasons,
we focus here on three SNPs of rs7524102, rs6696981, andrs6993813. Consequently, hip BMD had a positive association
with the rs6993813 SNP in Taiwanese women, but had
a negative association with the rs6696981 SNP. Compared to
individuals with C/C wild-type homozygotes, individuals with
T/T minor allele homozygotes of rs6993813 had a 9.53-fold
risk of developing hip osteoporosis as well. Two rs7524102
and rs6696981 SNPs in linkage disequilibrium on the 1p36
(ZBTB40) tend to be inherited together, and both show an
association with hip BMD,24 whereas we could not find that
the rs7524102 SNP has a similar effect on hip BMD or oste-
oporosis in the study. This may be one of the reasons that the
ethnic Taiwanese population has higher hip fracture rates.
Our study had several limitations. First, it is difficult to
identify the underlying genes of a complex polygenic trait
such as BMD by linkage studies, and it requires large numbers
of patients due to the limited power.39 Intriguingly, we
investigated an opposite association of rs6696981 and
rs6993813 SNPs with BMD of the hip and the minor allele
homozygotes of rs6993813 with an AOR of 9.53 for hip
osteoporosis. Second, the statistical power to identify linkage
signals for stature may miss some false negative results due to
the small sample size.40 This may be the reason why the
rs6696981 SNP possesses a protective effect by increasing the
BMD of the hip, although this effect is independent of hip
osteoporosis. However, this result should be validated in
a substantially larger cohort. Third, the diseaseegenotype
association produced by case-control studies may be spurious
when the genotype distribution of healthy controls deviates
from HardyeWeinberg equilibrium, as in the case of the
rs6993813 SNP. Even so, the HardyeWeinberg equilibrium
may be affected by many factors, including sample size,
selection bias, and laboratory errors.41 Moreover, a standard
adjustment of ORs for allele frequencies still does not exist.42
Accordingly, we clarified this issue, including study design
and limitation, and still calculated AORs to measure the
association in order to avoid missing the ultimate finding.
In conclusion, our study has provided strong evidence that
polymorphic variants in the OPG gene (rs6993813) and
ZBTB40 gene (rs6696981) have an opposite association with
hip BMD in elderly Taiwanese women. The rs6993813 SNP
with T/T homozygotes has strong decreasing effects on hip
BMD and the risk to develop hip osteoporosis. The rs6696981
SNP with G/T and T/T genotypes may be considered a factor
affecting decreased susceptibility to hip osteoporosis. These
advances in knowledge about the genetic basis of osteoporosis
have noteworthy strengths and provide us with new genetic
markers with which to assess fracture risk and to prevent
future fractures in postmenopausal Taiwanese women. This
observation, of course, needs to be replicated in other depen-
dent or independent populations, especially in postmenopausal
Chinese women.
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